Sofinnova Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Sofinnova Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$88M	Sell	365,341 -232,986	-39%	-$51M	4.55%	4
2026 Q1	$113M	Sell	598,327 -361,533	-38%	-$63.2M	4.3%	5
2025 Q4	$163M	Buy	959,860 +371,032	+63%	+$56.9M	7.04%	2
2025 Q3	$77.6M	Sell	588,828 -105,268	-15%	-$12.6M	4.24%	5
2025 Q2	$73.7M	Buy	694,096 +184,046	+36%	+$20M	4.51%	4
2025 Q1	$63.3M	Buy	510,050 +5,857	+1%	+$764K	4.14%	6
2024 Q4	$62.1M	Buy	504,193 +315,631	+167%	+$37.2M	4.52%	5
2024 Q3	$21M	Buy	+188,562	New	+$20.7M	1.67%	19
2021 Q2	–	Sell	-255,928	Closed	-$42.1M	–	71
2021 Q1	$42.1M	Buy	255,928 +43,017	+20%	+$7.08M	2.53%	9
2020 Q4	$35.1M	Buy	212,911 +82,643	+63%	+$12.3M	2.09%	10
2020 Q3	$18.6M	Sell	130,268 -113,085	-46%	-$14M	1.38%	19
2020 Q2	$26.9M	Buy	+243,353	New	+$26.9M	1.69%	15

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Sofinnova Investments's JAZZ Position: Q2 2026 in Review

Sofinnova Investments reduced its Jazz Pharmaceuticals (JAZZ) stake by 39% in Q2 2026, selling an estimated $51M and leaving 365,341 shares worth $88M. The position accounts for 4.55% of the portfolio, ranked #4.

Sofinnova Investments first reported a position in JAZZ in Q2 2020 and has held it in 12 quarters since. The position peaked at $163M in Q4 2025. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Sofinnova Investments held 365,341 shares of Jazz Pharmaceuticals worth $88M as of Q2 2026.
Sofinnova Investments sold 232,986 Jazz Pharmaceuticals shares in Q2 2026, an estimated $51M.
Jazz Pharmaceuticals made up 4.55% of Sofinnova Investments's portfolio in Q2 2026, its #4 holding.
Sofinnova Investments first reported a position in Jazz Pharmaceuticals in Q2 2020 and has held it in 12 quarters since.
Sofinnova Investments's Jazz Pharmaceuticals position peaked at $163M in Q4 2025.
646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Sofinnova Investments's 13F filing for Q2 2026, filed 14 Aug 2026.